PSUSA/00001760/202501
Submitted by Anonymous (not verified) on 2 October 2025 - 15:44
PSUSA/00001760/202501
PSUSA/00001028/202411
Submitted by Anonymous (not verified) on 2 October 2025 - 15:35
PSUSA/00001028/202411
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2025 - 15:20
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised
VICH GL62 on target animal safety of veterinary monoclonal antibody products (VMAPs) St4
Submitted by Anonymous (not verified) on 2 October 2025 - 15:14
VICH GL62 on target animal safety of veterinary monoclonal antibody products (VMAPs) St4
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 23, Status: Authorised
Submitted by Anonymous (not verified) on 2 October 2025 - 15:00
Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 23, Status: Authorised
Agenda - Management Board meeting: 2 October 2025
Submitted by Anonymous (not verified) on 2 October 2025 - 14:30
Agenda - Management Board meeting: 2 October 2025
Agenda - Management Board meeting: 2 October 2025
Submitted by Anonymous (not verified) on 2 October 2025 - 14:30
Agenda - Management Board meeting: 2 October 2025
Fees payable to the European Medicines Agency
Submitted by Anonymous (not verified) on 2 October 2025 - 14:20
Fees payable to the European Medicines Agency
HMPC: overview of assessment work - priority list
Submitted by Anonymous (not verified) on 2 October 2025 - 13:08
HMPC: overview of assessment work - priority list
Minutes - Enpr-EMA Coordinating Group & networks meeting - June 2025
Submitted by Anonymous (not verified) on 2 October 2025 - 12:53
Minutes - Enpr-EMA Coordinating Group & networks meeting - June 2025